Status:
UNKNOWN
A Prehabilitation Program for Frail Patients Undergoing Cardiac Surgeries/Procedures
Lead Sponsor:
The University of Hong Kong
Conditions:
Coronary Artery Bypass Grafting
Heart Valve Replacement
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to develop and evaluate a frailty-specific prehabilitation program for patients awaiting cardiac surgeries/procedures. The program aims to improve functional capacity, fra...
Detailed Description
Cardiovascular disease is a major cause of disability and morbidity worldwide. With advances in medical technology and care, patients with cardiovascular disease often live to an advanced age. In the ...
Eligibility Criteria
Inclusion Criteria:
- A confirmed schedule for elective CABG, valve repair/replacement, or combined CABG and valve repair/replacement, or TAVI
- Mild to moderate frailty at the time of recruitment, indicated by a Clinical Frailty Scale score between 4 and 6
- At least 5 weeks of procedural waiting time
- Physically fit for prehabilitation according to the surgeon/cardiologist's endorsement on a risk-assessment checklist
- Living with family
- Using an electronic device with internet access (patient/family).
Exclusion Criteria:
- Impaired cognition (Abbreviated Mental Test score ≤6) or communication
- With physical limitations to exercise
Key Trial Info
Start Date :
December 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06323317
Start Date
December 18 2023
End Date
March 31 2025
Last Update
March 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Polly Wai Chi
Hong Kong, Please Select, Hong Kong, 00000